New Harvard study declares winner between Pfizer and Moderna vaccines | TheHill - The Hill

Most Covid Vaccines Will Work as Boosters, Study Suggests The New York Times HealthWatch: Study Fins Moderna's COVID-19 Vaccine More Effective Than Pfizer's WJZ Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial The Lancet Covid-19 live updates: Many vaccines offer protection as boosters; Pfizer and Moderna may work best, study says The Washington Post
https://bit.ly/3xRdfZn